Homo sapiens Protein: ANO5
Summary
InnateDB Protein IDBP-36122.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol ANO5
Protein Name anoctamin 5
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000315371
InnateDB Gene IDBG-36120 (ANO5)
Protein Structure
UniProt Annotation
Function Does not exhibit calcium-activated chloride channel (CaCC) activity.
Subcellular Localization Endoplasmic reticulum membrane; Multi-pass membrane protein. Cell membrane. Note=Colocalized with CALR/calreticulin. Shows an intracellular localization according to PubMed:22075693.
Disease Associations Gnathodiaphyseal dysplasia (GDD) [MIM:166260]: Rare skeletal syndrome characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbone. Patients experience frequent bone fractures caused by trivial accidents in childhood; however the fractures heal normally without bone deformity. The jaw lesions replace the tooth-bearing segments of the maxilla and mandible with fibrous connective tissues, including various amounts of cementum-like calcified mass, sometimes causing facial deformities. Patients also have a propensity for jaw infection and often suffer from purulent osteomyelitis-like symptoms, such as swelling of and pus discharge from the gums, mobility of the teeth, insufficient healing after tooth extraction and exposure of the lesions into the oral cavity. {ECO:0000269PubMed:15124103}. Note=The disease is caused by mutations affecting the gene represented in this entry.Limb-girdle muscular dystrophy 2L (LGMD2L) [MIM:611307]: An autosomal recessive degenerative myopathy characterized by proximal weakness, weakness of the hip and shoulder girdles and prominent asymmetrical quadriceps femoris and biceps brachii atrophy. {ECO:0000269PubMed:20096397}. Note=The disease is caused by mutations affecting the gene represented in this entry.Miyoshi muscular dystrophy 3 (MMD3) [MIM:613319]: A late- onset muscular dystrophy characterized by distal muscle weakness of the lower limbs, calf muscle discomfort and weakness, quadriceps atrophy. Muscle weakness and atrophy may be asymmetric. {ECO:0000269PubMed:20096397, ECO:0000269PubMed:22499103}. Note=The disease is caused by mutations affecting the gene represented in this entry.
Tissue Specificity Highly expressed in brain, heart, kidney, lung, and skeletal muscle. Weakly expressed in bone marrow, fetal liver, placenta, spleen, thymus, osteoblasts and periodontal ligament cells. {ECO:0000269PubMed:15067359, ECO:0000269PubMed:15124103}.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 2 experimentally validated interaction(s) in this database.
Experimentally validated
Total 2 [view]
Protein-Protein 2 [view]
Protein-DNA 0
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Gene Ontology

Molecular Function
Accession GO Term
GO:0005229 intracellular calcium activated chloride channel activity
Biological Process
GO:0006821 chloride transport
GO:0034220 ion transmembrane transport
GO:0055085 transmembrane transport
GO:1902476 chloride transmembrane transport
Cellular Component
GO:0005622 intracellular
GO:0005789 endoplasmic reticulum membrane
GO:0005886 plasma membrane
GO:0016021 integral component of membrane
GO:0031982 vesicle
Protein Structure and Domains
PDB ID
InterPro IPR007632 Anoctamin
PFAM PF04547
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q75V66
PhosphoSite PhosphoSite-Q75V66
TrEMBL
UniProt Splice Variant
Entrez Gene 203859
UniGene Hs.619841
RefSeq NP_998764
HUGO HGNC:27337
OMIM 608662
CCDS CCDS31444
HPRD 10558
IMGT
EMBL AB125267
GenPept BAD17859